{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:23:55Z","timestamp":1787102635931,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010390","name":"Saint Louis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY026071"],"award-info":[{"award-number":["R01 EY026071"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.virusres.2026.199773","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:23:59Z","timestamp":1782851039000},"page":"199773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vaccination with an HSV-1 virus containing CD-137L reduces herpetic corneal disease when used both prophylactically and therapeutically"],"prefix":"10.1016","volume":"371","author":[{"given":"Patrick M.","family":"Stuart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziao-Tang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2026.199773_bib0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/OPTH.S80475","article-title":"Herpes simplex keratitis:challenges in diagnosis and clinical management","volume":"Volume 11","author":"Azher","year":"2017","journal-title":"Clin. Ophth."},{"key":"10.1016\/j.virusres.2026.199773_bib0017","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.antiviral.2018.06.010","article-title":"Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in mice","volume":"156","author":"Bernier","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2026.199773_bib0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2013.05.001","article-title":"Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis","volume":"58","author":"Burrel","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1712691","article-title":"Design and immunogenicity of a quadrivalent mRNA vaccine targeting HSV-2 with comparative evaluation of co-formulated and admixed formulations","volume":"16","author":"Cho","year":"2025","journal-title":"Front. Immunol."},{"issue":"Suppl","key":"10.1016\/j.virusres.2026.199773_bib0005","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/505359","article-title":"The cycle of human herpes simplex virus infection: virus transport and immune control","volume":"194","author":"Cunningham","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199773_bib0023","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4049\/jimmunol.159.4.1945","article-title":"Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10","volume":"159","author":"Daheshia","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2026.199773_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01036-18","article-title":"Attenuated Herpes Simplex virus 1 (HSV-1) expressing a mutant form of ICP6 stimulates a strong immune response that protects mice against HSV-1-induced corneal disease","volume":"92","author":"Davido","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008795","article-title":"An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection","volume":"16","author":"Egan","year":"2020","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.virusres.2026.199773_bib0012","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.virusres.2026.199773_bib0004","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1073\/pnas.022301899","article-title":"Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice","volume":"99","author":"Feldman","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2026.199773_bib0018","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1039\/D2RA06749H","article-title":"Antiviral activity of amide-appended \u03b1-hydroxytropolones against herpes simplex virus-1 and -2","volume":"13","author":"Gazquez Casals","year":"2023","journal-title":"RSC. Adv."},{"key":"10.1016\/j.virusres.2026.199773_bib0019","first-page":"1352","article-title":"Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins","volume":"36","author":"Ghiasi","year":"1995","journal-title":"IOVS"},{"key":"10.1016\/j.virusres.2026.199773_bib0034","doi-asserted-by":"crossref","first-page":"15920","DOI":"10.1038\/s41598-022-20180-0","article-title":"HSV-1 0\u2206NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition","volume":"12","author":"Gmyrek","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2026.199773_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/eye.1995.14","article-title":"Immunisation against HSV-1 keratitis with a synthetic gD peptide","volume":"9","author":"Heilingenhaus","year":"1995","journal-title":"Eye"},{"key":"10.1016\/j.virusres.2026.199773_bib0021","first-page":"411","article-title":"Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis","volume":"31","author":"Inoue","year":"1990","journal-title":"IOVS"},{"key":"10.1016\/j.virusres.2026.199773_bib0052","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199773_bib0024","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/514049","article-title":"Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice","volume":"176","author":"Keadle","year":"1997","journal-title":"J. Infec. Dis."},{"key":"10.1016\/j.virusres.2026.199773_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/mpat.2002.0506","article-title":"CD4+ and CD8+ cells are key participants in the development of recurrent herpetic stromal keratitis in mice","volume":"32","author":"Keadle","year":"2002","journal-title":"Microb. Pathogen."},{"key":"10.1016\/j.virusres.2026.199773_bib0025","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1128\/JVI.76.8.3615-3625.2002","article-title":"Therapeutic immunization with a virion host shutoff (vhs) defective, replication-incompetent HSV-1 strain limits recurrent herpetic ocular infection","volume":"76","author":"Keadle","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrmicro1794","article-title":"Chromatin control of herpes simplex virus lytic and latent infection","volume":"6","author":"Knipe","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virusres.2026.199773_bib0038","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/eji.200323996","article-title":"4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D2 and E and cyclin-dependent kinase (cdk) inhibitor p27kip1","volume":"33","author":"Lee","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virusres.2026.199773_bib0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.1300453","article-title":"Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice","volume":"192","author":"Lee","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2026.199773_bib0051","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1084\/jem.189.4.663","article-title":"Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo","volume":"189","author":"Leib","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virusres.2026.199773_bib0009","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/nm.2051","article-title":"Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency","volume":"15","author":"Liang","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2026.199773_bib0042","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.182.2.934","article-title":"Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease","volume":"182","author":"Lin","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.virusres.2026.199773_bib0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003226-199609000-00010","article-title":"A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice","volume":"15","author":"Miller","year":"1996","journal-title":"Cornea"},{"key":"10.1016\/j.virusres.2026.199773_bib0022","first-page":"1679","article-title":"Intramuscular vaccination of rabbits with expressed HSV-2 glycoproteins B+D (gD2+gD2) protects against death following ocular HSV-1 challenge but not from eye disease","volume":"35","author":"Nesburn","year":"1994","journal-title":"IOVS"},{"key":"10.1016\/j.virusres.2026.199773_bib0032","doi-asserted-by":"crossref","unstructured":"C. Petro, P.A. Gonz\u00e1lez, N. Cheshenko, T. Jandl 2015. Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease. Elife: 10.7554\/eLife.06054.","DOI":"10.7554\/eLife.06054.016"},{"key":"10.1016\/j.virusres.2026.199773_bib0033","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88529","article-title":"HSV-2 \u0394gD elicits fc\u03b3r-effector antibodies that protect against clinical isolates","volume":"1","author":"Petro","year":"2016","journal-title":"JCI. Insight."},{"key":"10.1016\/j.virusres.2026.199773_bib0002","first-page":"1","article-title":"Repression of viral transcription during herpes simplex virus latency","volume":"81","author":"Preston","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0029","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1128\/JVI.77.12.6692-6699.2003","article-title":"Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice","volume":"77","author":"Richards","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0039","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.4049\/jimmunol.180.8.5267","article-title":"CD137 costimulation of CD8+ T cells confers resistance to suppression by virus-induced regulatory T cells","volume":"180","author":"Robertson","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2026.199773_bib0014","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2012.08.002","article-title":"Herpes keratitis","volume":"32","author":"Rowe","year":"2013","journal-title":"Prog. Retinal Eye Res."},{"key":"10.1016\/j.virusres.2026.199773_bib0030","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1128\/JVI.00517-16","article-title":"A highly efficacious Herpes Simplex virus 1 vaccine blocks viral pathogenesis and prevents corneal immunopathology via humoral immunity","volume":"90","author":"Royer","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02342-16","article-title":"Impact of type I interferon on the safety and immunogenicity of an experimental live-attenuated Herpes simplex virus 1 vaccine in mice","volume":"91","author":"Royer","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0010","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3109\/02713688909000044","article-title":"An improved model of recurrent herpetic eye disease in mice","volume":"8","author":"Shimeld","year":"1989","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.virusres.2026.199773_bib0011","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1099\/0022-1317-71-3-681","article-title":"Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system","volume":"71","author":"Shimeld","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0037","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.186.1.47","article-title":"4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses","volume":"186","author":"Shuford","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virusres.2026.199773_bib0007","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/343739","article-title":"Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review","volume":"186","author":"Smith","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199773_bib0003","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/JVI.75.11.5069-5075.2001","article-title":"Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread","volume":"75","author":"Summers","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0001","series-title":"editors. Ophthalmology, 3rd Edition, \u00a9 2009","article-title":"Herpes simplex keratitis. In:","author":"Tuli","year":"2009"},{"key":"10.1016\/j.virusres.2026.199773_bib0008","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s007050050533","article-title":"Evolution of herpes simplex virus type 1 under herpesvirus evolutionary processes","volume":"144","author":"Umene","year":"1999","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0264-410X(97)00164-3","article-title":"Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function","volume":"16","author":"Walker","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199773_bib0027","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0264-410X(97)00177-1","article-title":"Postexposure vaccination with a virion host shutoff defective mutant reduces UV-B radiation-induced ocular herpes simplex virus shedding in mice","volume":"16","author":"Walker","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199773_bib0048","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/v14050869","article-title":"Efficacy of an HSV-1 Neuro-attenuated vaccine in mice is reduced by preventing viral DNA replication","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199773_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.128107","article-title":"Direct comparison of three herpes simplex virus-2 vaccine candidates using peripheral or mucosal routes of vaccination","volume":"75","author":"Wang","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199773_bib0041","doi-asserted-by":"crossref","first-page":"eo7486","DOI":"10.7554\/eLife.07486","article-title":"The viral context instructs the redundancy of costimulatory pathways in driving CD8+ T cell expansion","volume":"4","author":"Welten","year":"2015","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.virusres.2026.199773_bib0044","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.4049\/jimmunol.1302957","article-title":"CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis","volume":"192","author":"West","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2026.199773_bib0036","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001756","article-title":"CD137 costimulation is associated with reduced herpetic stromal keratitis and with developing normal CD8+ T cells in trigeminal ganglia","volume":"103","author":"Yin","year":"2022","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2026.199773_bib0046","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.immuni.2020.10.013","article-title":"Production of the Cytokine VEGF-A by CD4+ T and myeloid cells disrupts the corneal nerve landscape and promotes Herpes stromal keratitis","volume":"53","author":"Yun","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2026.199773_bib0043","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901619","article-title":"CD137 promotes proliferation and survival of human B cells","volume":"184","author":"Zhang","year":"2010","journal-title":"J. Immunol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:26:47Z","timestamp":1787099207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"alternative-id":["S0168170226000924"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199773","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with an HSV-1 virus containing CD-137L reduces herpetic corneal disease when used both prophylactically and therapeutically","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199773"}}